CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $5.7M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.68% less ownership
Funds ownership: 20.15% → 15.46% (-4.7%)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$595K | |
| 2 | +$274K | |
| 3 | +$269K | |
| 4 |
RPG
Risk Paradigm Group
Austin,
Texas
|
+$16.1K |
| 5 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$9.33K |
Top Sellers
| 1 | -$52.8K | |
| 2 | -$35.7K | |
| 3 | -$17K | |
| 4 |
Morgan Stanley
New York
|
-$2K |